Answers are grounded in this paper and cite their sources.
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL.
No takes yet. Share an insight, caveat, or question.
Hoppe et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: